This reflects our continued commitment to strengthening our diabetes portfolio with high-impact, patient-centric solutions, while leveraging our strong presence in chronic care to drive rapid adoption and expand access across India
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide
These HCSC plans share formulary architecture, meaning the Wegovy coverage logic is the same shape across both states: commercial weight-loss coverage is employer-dependent, ACA plans generally exclude it, and specific drug-level detail is not publicly published
Endocrine and Glucose Signaling
Comment: Commenters supported the proposed APC assignments for CPT codes 78431 and 78433 for CY 2026 based on our analysis of the available claims data
This content is for informational purposes only and is not intended as medical advice